Reviews

Targeting Cbl-b in cancer immunotherapy
Ryan C. Augustin, Riyue Bao, Jason J. Luke

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006007; DOI: 10.1136/jitc-2022-006007
Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy
Lavanya Sivapalan, Joseph C Murray, Jenna VanLiere Canzoniero, Blair Landon, Jennifer Jackson, Susan Scott, Vincent Lam, Benjamin P. Levy, Mark Sausen, Valsamo Anagnostou

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005924; DOI: 10.1136/jitc-2022-005924
Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy
Simon Deycmar, Bruno Gomes, Jehad Charo, Maurizio Ceppi, J Mark Cline

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005514; DOI: 10.1136/jitc-2022-005514
Dose–response correlation for CAR-T cells: a systematic review of clinical studies
Anand Rotte, Matthew J Frigault, Ayub Ansari, Brad Gliner, Christopher Heery, Bijal Shah

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005678; DOI: 10.1136/jitc-2022-005678
Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation
Klaus Pantel, Catherine Alix-Panabières

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e005615; DOI: 10.1136/jitc-2022-005615
Imaging endpoints for clinical trial use: a RECIST perspective
Saskia Litière, Jan Bogaerts

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005092; DOI: 10.1136/jitc-2022-005092
Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects
Maximilian Boesch, Lena Horvath, Florent Baty, Andreas Pircher, Dominik Wolf, Stephan Spahn, Ravid Straussman, Herbert Tilg, Martin H Brutsche

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005401; DOI: 10.1136/jitc-2022-005401
Combining precision oncology and immunotherapy by targeting the MALT1 protease
Thorsten R Mempel, Daniel Krappmann

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005442; DOI: 10.1136/jitc-2022-005442
Antitumor strategies targeting macrophages: the importance of considering the differences in differentiation/polarization processes between human and mouse macrophages
Marine Monnier, Léa Paolini, Emeline Vinatier, Alberto Mantovani, Yves Delneste, Pascale Jeannin

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005560; DOI: 10.1136/jitc-2022-005560
OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases
Michael Thiele, Seamas C Donnelly, Robert A Mitchell

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005475; DOI: 10.1136/jitc-2022-005475

Main menu

Reviews

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Reviews

Pages